Importance Cardiovascular disease (CVD) is the leading cause of morbidity and death in the
US and is the cause of more than 1 of every 4 deaths. Coronary heart disease is the single …

Background Severe coronavirus disease 2019 (COVID‐19) is characterized by a
proinflammatory state with high mortality. Statins have anti‐inflammatory effects and may …

Purpose of review Racial, ethnic, and gender disparities in cardiovascular care are well-
documented. This review aims to highlight the disparities and impact on a group particularly …

The 2018 American College of Cardiology/American Heart Association Guideline on the
Management of Blood Cholesterol recommends statin therapy for eligible patients to reduce …

Background Diabetes mellitus-related characteristics, including available medications, onset
ages, and newly-introduced management program, have been changing recently in Hong …

Background Type 2 diabetes is 2–3 times more prevalent in people of South Asian and
African/African Caribbean ethnicity than people of European ethnicity living in the UK. The …

Importance Based on contemporary estimates in the US, evidence-based therapies for
cardiovascular risk reduction are generally underused among patients with type 2 diabetes …

Objectives. To determine whether intersectional stigma is longitudinally associated with
biopsychosocial outcomes. Methods. We measured experienced intersectional stigma …

Background: Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of
mortality in the United States. The purpose of this study is to examine the rates of statin use …

Background Risks for cardiovascular diseases, including myocardial infarction and stroke,
are elevated in people with HIV infection (PWH). However, no trials of statin utilization with …